Dato’ Terence Tea Yeok Kian
Executive Chairman and Managing Director
Board of DirectorsThe business, the people and the ownership behind Accrelist Ltd.
Business overview
Accrelist invests in and operates businesses with a growing focus on medical aesthetics. Its subsidiaries include the A.M Aesthetics group of medical aesthetics businesses and A.M Skincare.
Listed security
Board & management
Executive Chairman and Managing Director
Board of DirectorsLead Independent Director
Board of DirectorsIndependent and Non-Executive Director
Board of DirectorsIndependent and Non-Executive Director
Board of DirectorsRoles listed in Accrelist Ltd. Annual Report 2026; current appointments are not independently verified.
Holdings
Direct interest 16,200,000 shares (5.05%); deemed interest nil (–, 0.00%)
Substantial shareholder, ordinary sharesTotal interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-06-29 · PDF p. 139
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| TERENCE TEA YEOK KIAN | 90,881,106 shares; 28.31% | PDF p. 1392026-06-29 | |
| PHILLIP SECURITIES PTE LTD | 46,902,453 shares; 14.61% | PDF p. 1392026-06-29 | |
| OCBC SECURITIES PRIVATE LTD | 21,862,182 shares; 6.81% | PDF p. 1392026-06-29 | |
| HSBC (SINGAPORE) NOMINEES PTE LTD | 13,224,100 shares; 4.12% | PDF p. 1392026-06-29 | |
| TOH SOON HUAT | 9,731,515 shares; 3.03% | PDF p. 1392026-06-29 | |
| LOH JU EE KAREN | 7,400,000 shares; 2.3% | PDF p. 1392026-06-29 | |
| MAYBANK SECURITIES PTE. LTD. | 7,200,396 shares; 2.24% | PDF p. 1392026-06-29 | |
| UNITED OVERSEAS BANK NOMINEES PTE LTD | 5,729,913 shares; 1.78% | PDF p. 1392026-06-29 | |
| DBS NOMINEES PTE LTD | 4,980,530 shares; 1.55% | PDF p. 1392026-06-29 | |
| LEE BEE SENG | 4,878,481 shares; 1.52% | PDF p. 1392026-06-29 | |
| LEE WEE KIEN | 4,694,400 shares; 1.46% | PDF p. 1392026-06-29 | |
| LOH ENG LOCK KELVIN (LU RONGLU KELVIN) | 4,258,718 shares; 1.33% | PDF p. 1392026-06-29 | |
| TAN SIAK LIAN | 4,037,204 shares; 1.26% | PDF p. 1392026-06-29 | |
| DECOR INDUSTRIES PTE LTD | 4,000,000 shares; 1.25% | PDF p. 1392026-06-29 | |
| MOOMOO FINANCIAL SINGAPORE PTE. LTD. | 3,200,000 shares; 1.00% | PDF p. 1392026-06-29 | |
| DBS VICKERS SECURITIES (S) PTE LTD | 3,006,300 shares; 0.94% | PDF p. 1392026-06-29 | |
| LIM KIAN HONG (LIN JIAN HONG) | 2,968,400 shares; 0.92% | PDF p. 1392026-06-29 | |
| CITIBANK NOMINEES SINGAPORE PTE LTD | 2,508,535 shares; 0.78% | PDF p. 1392026-06-29 | |
| MARILYN TAY BEE CHOO | 2,000,000 shares; 0.62% | PDF p. 1392026-06-29 | |
| YAP KOK FONG | 1,750,000 shares; 0.55% | PDF p. 1392026-06-29 | |
Group structure
| Company | Market | Ownership interest |
|---|---|---|
| A.M. Skincare Pte. Ltd.Held by the Company; Singapore; 2026 (2025: 100.0)PDF p. 114 | 100.0% | |
| WesCal Electronics Trading (Shanghai) Co., Ltd. (4)Held by the Company; People’s Republic of China; 2026 (2025: 100.0)PDF p. 114 | 100.0% | |
| WE Electronics Co., Ltd. (4)Held by the Company; Thailand; 2026 (2025: 100.0)PDF p. 114 | 100.0% | |
| WE Resources Sdn. Bhd. (2)Held by the Company; Malaysia; 2026 (2025: 100.0)PDF p. 114 | 100.0% | |
| WE Technology (HK) Ltd. (4)Held by the Company; Hong Kong; 2026 (2025: 100.0)PDF p. 114 | 100.0% | |
| WE Resources (Cambodia) Co. Ltd. (4)Held by the Company; Cambodia; 2026 (2025: 100.0)PDF p. 114 | 100.0% | |
| Accrelist Crowdfunding Pte. Ltd. (1)Held by the Company; Singapore; 2026 (2025: 100.0)PDF p. 114 | 100.0% | |
| Accrelist Medical Aesthetics (BM) Pte. Ltd. (1)Held by the Company; Singapore; 2026 (2025: 100.0)PDF p. 114 | 100.0% | |
| Jubilee Industries Holdings Ltd. (1)Held by the Company (cont’d); Singapore; 2026 (2025: 52.5)PDF p. 115 | 52.5% | |
| SJY Medical Pte Ltd (4)Held by the Company; Singapore; 2026 (2025: 51.0)PDF p. 115 | 51.0% | |
| Accrelist Medical Aesthetics (CM) Pte. Ltd. (1)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Singapore; 2026 (2025: 100.0)PDF p. 115 | 100.0% | |
| Accrelist Aesthetics (KL) Sdn. Bhd. (2a)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Malaysia; 2026 (2025: 100.0)PDF p. 115 | 100.0% | |
| Accrelist Medical Aesthetics (Penang) Sdn. Bhd. (2a)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Malaysia; 2026 (2025: 100.0)PDF p. 115 | 100.0% | |
| Accrelist Medical Aesthetics (Central@Clarke Quay) Pte. Ltd. (1)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Singapore; 2026 (2025: 100.0)PDF p. 115 | 100.0% | |
| Accrelist Medical Aesthetics (Orchard Central) Pte. Ltd. (1)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Singapore; 2026 (2025: 100.0)PDF p. 115 | 100.0% | |
| Accrelist Medical Aesthetics (Northpoint) Pte. Ltd. (1)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Singapore; 2026 (2025: 100.0)PDF p. 115 | 100.0% | |
| Accrelist Medical Aesthetics (China) Pte. Ltd. (4)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd. (cont’d); Singapore; 2026 (2025: 100.0)PDF p. 116 | 100.0% | |
| Accrelist Medical Aesthetics (Serangoon) Pte. Ltd. (1)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Singapore; 2026 (2025: 100.0)PDF p. 116 | 100.0% | |
| Accrelist Medical Aesthetics (Raffles City) Pte. Ltd. (1)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Singapore; 2026 (2025: 100.0)PDF p. 116 | 100.0% | |
| Accrelist Medical Aesthetics (LOT1) Pte. Ltd. (1)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Singapore; 2026 (2025: 100.0)PDF p. 116 | 100.0% | |
| Accrelist Medical Aesthetics (SPC) Pte. Ltd. (1)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Singapore; 2026 (2025: 100.0)PDF p. 116 | 100.0% | |
| Accrelist Medical Aesthetics (TPY) Pte. Ltd. (1)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Singapore; 2026 (2025: 100.0)PDF p. 116 | 100.0% | |
| Accrelist Medical Aesthetics (Bangkok) Co., Ltd. (4)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; Thailand; 2026 (2025: 100.0)PDF p. 116 | 100.0% | |
| Accrelist Medical Aesthetics (Hainan) Co., Ltd. (4)Held through Accrelist Medical Aesthetics (BM) Pte. Ltd.; China; 2026 (2025: 95.0)PDF p. 116 | 95.0% | |
| AM Aesthetics (J) Sdn. Bhd.(3a)(5)Held through Accrelist Medical Aesthetics (Penang) Sdn Bhd; Malaysia; 2026 (2025: 100.0)PDF p. 117 | 100.0% | |
| ACF Sdn. Bhd.(3a)(6)Held through Accrelist Crowdfunding Pte. Ltd.; Malaysia; 2026 (2025: –)PDF p. 117 | 100.0% | |
| Jubilee Industries (S) Pte Ltd (1)Held through Jubilee Industries Holdings Ltd.; Singapore; 2026 (2025: 52.5)PDF p. 117 | 52.5% | |
| J Capital Pte Ltd (1)Held through Jubilee Industries Holdings Ltd.; Singapore; 2026 (2025: 52.5)PDF p. 117 | 52.5% | |
| WE Total Engineering Sdn. Bhd. (3b)Held through Jubilee Industries (S) Pte. Ltd.; Malaysia; 2026 (2025: 52.5)PDF p. 117 | 52.5% | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Mr Derek Cheong Sheng Ze | Chief Executive Officer | Key management personnel, FY2026 remuneration table | PDF p. 32 |
| Mr Loh Eng Lock, Kelvin | Chief Financial Officer; Joint Company Secretary | Key management personnel, FY2026 remuneration table | PDF p. 32 |
Extracted from Accrelist Ltd. Annual Report 2026 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Jubilee Industries Holdings Ltd. | S$378,000 | Group, FY2026, management fee received by the Company from Jubilee Industries Holdings Ltd. (52.5%-owned subsidiary, associate of a director and controlling shareholder); aggregate value under shareholders' mandate: Nil | PDF p. 39 |
| Remuneration of directors of the Company | 1,085 S$'000 | Group, 2026 (comparative 2025: 946) | PDF p. 126 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Corporate guarantees | The Company has issued corporate guarantees to banks for borrowings of a subsidiary (Note 27(a)). | Company | PDF p. 125 |
| Financial support | No liabilities are recognised by the Company and its subsidiaries as it is considered unlikely that there will be significant outflows of resources made by the Company as a result of the financial support provided. | Company and one subsidiary | PDF p. 125 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Dato’ Terence Tea Yeok Kian | 269,262 S$ | FY2026 total remuneration; breakdown 73% salary, 15% bonus, 12% fringe benefits | PDF p. 32 |
| Mr Chin Sek Peng | 48,000 S$ | FY2026 total remuneration; 80% directors' fees, 20% share incentive schemes | PDF p. 32 |
| Mr Chong Eng Wee | 56,000 S$ | FY2026 total remuneration; 80% directors' fees, 20% share incentive schemes | PDF p. 32 |
| Dr Tan Tze Sheng, Edwin | 40,000 S$ | FY2026 total remuneration; 80% directors' fees, 20% share incentive schemes | PDF p. 32 |
| Directors’ fees for FY2026 | S$180,000 | Independent and Non-Executive Directors, FY2026, approved at AGM held on 29 September 2025; the same aggregate is recommended for FY ending 31 March 2027 | PDF p. 31 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Total No. of Employees | 727 count | Group, FY2026 (FY2025: 671) | PDF p. 52 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Events after the reporting period | On 16 June 2026, the Group entered into a non-binding term sheet with a third party for the proposed acquisition of a 51% equity interest in a company to be incorporated in the People’s Republic of China (“Target Company”). | Group · As at 2026-06-16 | PDF p. 138 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Outlook and Future Plans | Looking ahead, we will continue to position A.M Aesthetics | Executive Chairman and Managing Director's Chairman's Message | PDF p. 5 |
| Chairman's closing outlook | we are confident in our ability to build | Executive Chairman and Managing Director's Chairman's Message | PDF p. 5 |
Extracted from Accrelist Ltd. Annual Report 2026 and checked against the cited pages; see the original report for full context.
Corporate information